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Summary
Background: Acute gastroenteritis and diarrhea are common and costly problems that cause
significant morbidity and mortality in children worldwide. In Palestine, diarrhea is one of the
major causes of outpatient visits and hospitalizations.
Methods: To improve knowledge on the etiology of gastroenteritis and diarrhea in our patient
population, stool specimens from 150 children under 5 years of age suffering from acute
gastroenteritis were investigated for various common bacterial enteropathogens by conventional
and molecular techniques.
Results: Bacterial enteropathogens were detected in 17.3% of the diarrheal samples. Shigella spp
was the most common bacterial pathogen (6.0%), followed by Campylobacter coli/jejuni (4.7%),
Escherichia coliO157:H7 (4.7%), and Salmonella spp (2.0%). Shigella and Salmonella isolates were
tested for their susceptibility to common antimicrobial agents and most of the Shigella isolates
were resistant to ampicillin, trimethoprim/sulfamethoxazole and doxycycline and most of the
Salmonella isolates showed resistant to ampicillin, trimethoprim/sulfamethoxazole, doxycycline
and nalidixic acid.
Conclusions: The results highlight the value of using a combination of traditional and molecular
techniques (PCR) in the diagnosis of bacterial gastroenteritis. Furthermore, this study demon-
strated that E. coli O157:H7 and Campylobacter, which are not screened for routinely in the Gaza
Strip, were significant enteropathogens.
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Acute gastroenteritis is one of the leading causes of illnesses
and death in infants and children throughout the world,
especially in developing countries. This is so in Asia, Africa
and Latin America, where an estimated 2.5 million deaths
occur each year in children under 5 years of age.1,2 Diarrhea
is also one of the leading causes of death among the popula-
tion of the Gaza Strip.3
Gastroenteritis is characterized by painful abdominal
cramps and frequent defecation of blood and mucus, attrib-
uted to penetration and destruction of colonic epithelia by
invasive microorganisms. Symptoms can include nausea,
vomiting, diarrhea, fever, abdominal cramping and/or pain
and a general feeling of tiredness. Approximately 9% of all
hospitalizations of children younger than 5 years are due to
diarrhea and dehydration.4
Investigations on diarrheal diseases in young children
demonstrated that Salmonella spp, Cryptosporidium spp,
Campylobacter spp and rotavirus were the major pathogens
in the Gaza Strip, and overcrowding was linked with an
increased risk of diarrhea.5,6
Worldwide, the most common bacterial pathogens that
cause this disease are: Salmonella spp, Shigella spp, Cam-
pylobacter spp, Escherichia coli O157:H7, Listeria monocy-
togenes, Vibrio cholerae, and Yersinia enterocolitica.7
These pathogens can cause potentially serious diseases,
whichmay be fatal, especially in children. The common route
of infection by these pathogens is the ingestion of contami-
nated foods and drinks.8
In Palestine, diarrhea is one of the major causes of out-
patient visits and hospitalizations. The identification and
diagnosis of bacterial gastroenteritis in the Gaza Strip health
laboratories is carried out only for Salmonella and Shigella
species, through culture, biochemical and serological assays;
however, stool samples are not routinely screened for Cam-
pylobacter and E. coli O157:H7.9
Data from the health laboratories all over the Gaza Strip
show that the detection rate of Salmonella spp is very low
(about 0.4% in the year 2004) and even lower for Shigella spp
(0.4, 1.2 and 0.12%, in the respective years 2002, 2003 and
2004). Moreover, data concerning cases of Campylobacter
and E. coli O157:H7 and their relation to infection in Pales-
tinian children are extremely scarce.9—11
One of the modern techniques for identifying entero-
pathogens relies on PCR amplification assays with specifically
designed nucleotide primers. PCR is suggested by many
investigators to be safer, more sensitive and more rapid than
the ordinary culture methods for the diagnosis of bacteria or
viruses.12 The use of PCR for detecting and identifying enteric
pathogens is rapid and easy while the conventional identifi-
cation methods are not only time consuming, but also require
an experienced laboratory technician to isolate and identify
bacterial colonies accurately. Studies in several parts of the
world have shown that the sensitivity and specificity of a
direct PCR method for the detection of enteric pathogens in
stool samples is quite high when compared to conventional
methods.13—15
In the present study both conventional and molecular
diagnostic (PCR) techniques were used for analyzing stool
samples collected from children under 5 years of age
with acute diarrhea, for the presence of the four commonbacterial enteropathogens: Salmonella spp, Shigella spp,
Campylobacter coli/jejuni, and E. coli O157:H7. Shigella
spp and Salmonella spp isolates were tested for their sus-
ceptibility to common antimicrobial agents.
Materials and methods
Study population
During the peak diarrheal season (May—August 2005), 150
children up to 5 years of age who were admitted to El Nasser
Pediatric Hospital Gaza (the central pediatric hospital in the
Gaza Strip) with acute diarrheal diseases were enrolled in the
study.
Sample collection
After informed consent was obtained, fecal samples (one per
subject) from children were collected as soon as they were
admitted to the hospital with the help of their parents. All
specimens were processed within 2 hours of collection.
Bacteriological investigation
All collected stool specimens were tested for Salmonella spp,
Shigella spp, and diarrheagenic E. coli (E. coli O157:H7).
Fresh stool samples were plated onto salmonella shigella (SS)
agar medium (Difco, USA), Hecktoen enteric (HE) agar (Difco,
USA), xylose lysine deoxycholate (XLD) agar (Difco, USA), and
sorbitol MacConkey agar (SMAC) (Himedia, India); the plates
were incubated for 18—24 h at 37 8C.
Approximately 1 g of each sample was inoculated into
10 ml of selenite cysteine broth (Himedia, India) and 10 ml
Gram-negative (GN) broth (Himedia, India), and the broth
was incubated for 18—24 h at 37 8C.
Subculture was done only for Salmonella and Shigella,
approximately 0.5 ml of selenite cysteine broth and GN broth
were subcultured onto SS agar, HE agar and XLD agar after
18—24 h of incubation.
Suspected colonies on the primary or subculture plates
resembling those of Salmonella, Shigella and E. coli O157:H7
were selected for further identification by standard labora-
tory procedures.16,17
Identification of E. coli, Salmonella and Shigella
Isolated bacteria were identified by their biochemical reac-
tion profile using Hy.enterotest (Hy.laboratories Ltd, Jerusa-
lem) and the API-20E test kit (bioMerieux, France). E. coli
O157 strains were also tested for the presence of glucuroni-
dase enzyme using a Violet Red with MUG media.18
The biochemical assays were supplemented with testing
for agglutination using the specific antisera: anti-Shigella
agglutination sera (BioRad, France), anti-Salmonella agglu-
tination sera (Difco, USA) and anti-E. coli O157:H7 latex test
kit (Plasmatic, UK).
Antimicrobial susceptibility testing by disk
diffusion
Antibiotic susceptibility of Salmonella and Shigella isolates
were determined using the disk diffusion method using
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Table 1 Sequence of the primers used in PCR
Organism Primer name Sequence 50 to 30 Annealing
temperature
Expected
product size
Reference
Shigella spp ipaH (F)—H8/15 50-GTTCCTTGACCGCCTTTCCGATAC-30 59 8C 700 bp 13
ipaH (R)—H8/3 50-GCCGGTCAGCCACCCTA-30
Salmonella spp 16S rDNA (F) 50-TGTTGTGGTTAATAACCGCA-30 56 8C 574 bp 21
16S rDNA (R) 50-CACAAATCCATCTCTGGA-30
E. coli O157:H7 UidA PT2 50-GCGAAAACTGTGGAATTGGG-30 55 8C 252 bp 22
UidA PT3 50-TGATGCTCCATAACTTCCTG-30
Campylobacter
coli/jejuni
16S rDNA CCCJ609F AATCTAATGGCTTAACCATTA 58 8C 854 bp 23
16S rDNA CCCJ1442R GTAACTAGTTTAGTATTCCGG
F: forward; R: reverse. All primers were synthesized by Operon Biotechnologies, Germany.Muller—Hinton agar (Sanofi Diagnostic Pasteur, France) as
described by the National Committee for Clinical Laboratory
Standards (NCCLS). The isolates were tested against the
following antibiotics: ampicillin, piperacillin, cephalexin,
cefuroxime, ceftazidime, ceftriaxone, amikacin, gentami-
cin, doxycycline, trimethoprim/sulfamethoxazole, cipro-
floxacin, nalidixic acid, chloramphenicol, cefaclor and
meropenem.19,20
DNA extraction
Approximately 0.2 g of each sample was used for DNA extrac-
tion. DNA was extracted from all the stool specimens using
the AccuPrep stool DNA extraction kit (Bioneer, Korea) fol-
lowing the manufacturer’s instructions.
PCR primers
Oligonucleotide primers for the PCR are shown in
Table 1.13,21—23
Detection of bacterial enteropathogens by PCR
Five microliters (200 ng) of the prepared DNA template was
added to 45 ml of PCR reaction mixture in 0.2 ml thin walled
microfuge tube. The reaction mixtures used in the PCR steps
contained 1 PCR buffer, 2.0 mM MgCl2, 0.1 mM of each
deoxynucleoside triphosphate, 1.0 mM of forward primer,
1.0 mM of reverse primer (as indicated in Table 1), and 2 U
of Taq DNA polymerase (Euroclone, Italy).Table 2 Bacterial enteropathogens identified in the 150 studied
Microorganism Number and perce
By PCR
n
Salmonella spp 3
Shigella spp 9
E. coli O157:H7 7
Campylobacter coli/jejuni 7
a Three cases of the Shigella spp were S. flexneri, two were S. sonni, a
b Not determined.DNA amplification was carried out in a Eppendorf Master-
cycler personal thermocycler using an initial denaturation
step of 95 8C for 3 min, followed by 35 cycles of amplification
with denaturation at 95 8C for 60 s, annealing (as indicated in
Table 1) for 60 s, and extension at 72 8C for 90 s, ending with a
final extension at 72 8C for 10 min. Upon completion of PCR,
the products were analyzed by ethidium bromide stained 2%
agarose gel electrophoresis.
Results
The study focused on detection and identification of the
commonly reported bacterial enteric pathogens in 150 chil-
dren under 5 years of age in Gaza, Palestine. The results of
the study are summarized below.
Detected bacterial enteropathogens
Using a combination of traditional and molecular diagnostic
techniques, we detected a bacterial enteropathogen in 26
cases (17.3%) of the diarrhea specimens examined. Table 2
shows the distribution of pathogens found in stools of the 150
children with diarrhea.
Shigella species were found in nine cases (6.0%) by PCR
(Figure 1(a)) and in only six cases (4.0%) by bacteriological
culture, with a higher frequency of S. flexneri (3/6) in
relation to S. sonnei (2/6), and S. boydii (1/6). Salmonella
spp were found in three cases (2.0% of diarrheal cases) as
revealed both by PCR (Figure 1(b)) and bacteriological cul-
ture. E. coli O157:H7 was found in seven cases (4.7%) by PCRspecimens
ntage of positive samples
By culture
(%) n (%)
(2.0) 3 (2.0)
(6.0) 6 (4.0) a
(4.7) 6 (4.0)
(4.7) NDb
nd one was S. boydii; no cases of S. dysenteriaewere encountered.
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Figure 2 Antibiotic resistance for Shigella isolates.
Figure 1 Specific amplification of (a) Shigella spp, (b) Salmonella spp, (c) E. coliO157:H7, and (d) Campylobacter coli/jejuni by PCR;
examples of some positive results. Amplified products of each reaction were analyzed by electrophoresis on ethidium bromide-stained
2.0% agarose gels. The bands in each figure correspond to the specific PCR product for each bacterial enteropathogen. (a) Specific
amplification of Shigella specific invasion plasmid antigen H locus DNA by PCR. Lane 1: 100-bp DNA ladder; lane 2: positive control; lane
4: negative control; and lane 3: PCR amplified DNA extracted from a stool sample positive for Shigella showing the 700-bp product. (b)
The 16S rDNA gene PCR assay specific for Salmonella spp. Lanes 1 and 15: 100-bp DNA ladder; lane 2: positive control; lanes 3 and 14:
negative control; lanes 4—13: tested sample; and lane 13: a stool sample positive for Salmonella showing the 574-bp product. (c) PCR
for identification of E. coli O157:H7 targeting uidA. All positive samples yielded an amplicon size of 252 bp. Lane 1: 100-bp DNA ladder;
lane 2: a negative control; lane 3: a blank; lane 4: a positive control; lane 5: an amplicon (252 bp) from DNA extracted directly from a
stool sample; and lane 6: stool samples showing negative sample. (d) 16S rDNA-based PCR assay specific for C. jejuni and C. coli. PCR
assay yields an 854-bp product. Lane 1: 100-bp DNA ladder; lane 2: negative control; lane 3 positive control; lanes 4—6 stool samples
showing positive samples in lanes 5 and 6 with the 854-bp product.(Figure 1(c)) and in six (4.0%) of the diarrheal cases by
bacteriological culture, while Campylobacter was evident
in seven (4.7%) of the diarrheal cases as revealed by PCR only
(Figure 1(d); Table 2).
PCR results
The main objective of this study was the specific
identification of the most common cause of bacterial
gastroenteritis.
The extracted DNA of the fecal samples was specifically
subjected to amplification for: Shigella-specific ipaH gene
using H8/15, H8/3 primers, 16S rDNA gene for Salmonella
species, uidA gene for E. coli O157:H7 using PT2, PT3 primers
and 16S rDNA gene for C. jejuni and C. coli using CCCJ609,
CCCJ1442 primers.
Of the 150 samples tested in our study, 124 samples were
negative for bacteria by PCR and 26 samples were positive by
PCR identification.
Figure 1a—d represent specific amplification of PCR
results for Shigella spp, Salmonella spp, E. coli O157:H7,
and Campylobacter coli/jejuni, respectively.PCR detected
all 100% for Salmonella spp, Shigella spp, and E. coli O157:H7
culture-positive pathogens and we detected three cases of
Shigella spp and one case of E. coli O157:H7 that were not
found by culture.Antimicrobial susceptibility of Shigella and
Salmonella isolates
The susceptibility of isolated Salmonella and Shigella species
to various antimicrobial drugs was determined by the disk
diffusion method following the recommendations of the
NCCLS. The antimicrobial agents used and the susceptibility
results of the Shigella and Salmonella isolates are shown in
Figures 2 and 3, respectively.
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Figure 3 Antibiotic resistance for Salmonella isolates.It is important to note here that some of the antibiotics
used were employed to characterize the isolates, but do not
have any clinical utility in the treatment of diarrhea in
children.
Antimicrobial susceptibility testing of Shigella strains
showed that 83% of the isolates were resistant to ampicillin,
trimethoprim/sulfamethoxazole and doxycycline, 33% to
piperacillin, cephalexin and chloramphenicol, and 17% to
cefuroxime, ceftazidime, ceftriaxone, cefaclor and genta-
micin. All isolates were sensitive to meropenem, nalidixic
acid, ciprofloxacin and amikacin (Figure 2).
Antimicrobial susceptibility testing of Salmonella strains
showed that 100% of the isolates were resistant to doxycycline
and nalidixic acid, 67% to ampicillin and trimethoprim/sulfa-
methoxazole, and 33% to piperacillin, cefaclor, gentamicin,
cefuroxime, cephalexin, ciprofloxacin and chloramphenicol.
All isolates were sensitive to meropenem, ceftriaxone, cefta-
zidime and amikacin (Figure 3).
It is important to note here that doxycycline and cipro-
floxacin are contraindicated for children.
Discussion
Diarrhea remains one of the most common illnesses in chil-
dren and one of the major causes of infant and childhood
mortality in developing countries. Considering the usually
scanty resources available in third world countries, a reduc-
tion in diarrhea-related mortality may be possible by identi-
fying high-risk subjects and targeting them for intensive
intervention.
The etiology of diarrhea is multifactorial (viral, parasites
and bacterial pathogens); viral infection is the most common
cause of diarrhea. Infections with bacterial pathogens peak
during the summertime when there are suitable conditions
such as humidity and high temperature, which facilitate
bacterial growth and dissemination.
Shigella was the first most common enteric pathogen
identified in the present study with an isolation rate of
6.0%. Shigella flexneriwas found with the highest prevalence
(50%) among the isolated Shigella spp emphasizing the impor-
tance of this pathogen in the epidemiology of childhood
bacterial diarrhea in Gaza, followed by S. sonnei; this finding
is consistent with other reports from developing countries
such as India, Bangladesh, Brazil, Tanzania, Egypt, and Thai-
land.24 The prevalence of Shigella recorded in this study issimilar to that reported by other investigators in many
neighboring countries such as Saudi Arabia, Jordan, Lebanon,
Kuwait, and Israel.25
Three cases (2%) proved positive for Salmonella both by
culture and PCR. Other reports from neighboring countries
indicate that the detection rate of Salmonella ranges from 2%
to 18%.25
E. coli O157:H7 was found in six (4.0%) diarrheal cases by
bacteriological culture. This microorganism is not routinely
analyzed in our clinical laboratories. E. coliO157:H7 has been
associated with 10—15% of bloody diarrheas by several inves-
tigators.26,27 Children with gastrointestinal infections caused
by E. coli O157:H7 are at risk for the hemolytic-uremic
syndrome (HUS), which can be fatal as it may lead to acute
kidney failure.
Campylobacter coli/jejuni was detected in 4.7% (7/150)
of the stool samples when analyzed by PCR assay. Conven-
tional identification of Campylobacter is known to be pro-
blematic because of their complex taxonomy, biochemical
inertness, and fastidious growth requirements.28,29
The results of the present study showed that PCR is
more rapid, sensitive and specific than conventional cul-
ture methods: Shigella spp was detected in 4.0% and in
6.0% of the stool samples when analyzed by the bacter-
iological culture and PCR assay, respectively. By the use of
PCR we found that three of the samples were Shigella spp-
positive by PCR and not by culture. E. coli O157:H7 was
detected in 4.0% and in 4.7% of the samples when analyzed
by conventional culture method and PCR, respectively. By
use of PCR we found one sample of E. coli O157:H7 that
was positive by PCR while it was not resolved by culture. In
total we found 4/19 (21.1%) enteropathogen-positive spe-
cimens by PCR that the bacteriological stool cultures failed
to detect.
PCR is a selective, sensitive, and specific assay that can
detect a small number of culturable as well as non-culturable
organisms. Such detection is especially important for shigel-
lae, since they can produce disease with as few as 10 to 100
organisms. In our study, the use of the PCR technique
improved the rate of detecting shigellae in stool samples
from six to nine positive samples, which is 33.3% (3/9) higher
than the conventional culture method. Moreover, the time
requirement of this technique (4 hours) is shorter when
compared to that of the culture technique (48—72 hours).
Hence, this PCR-based method contributes to improvement
of the rapid diagnosis of enteric bacterial infections, whilst
yielding higher detection rates of causative agents.
The assay was extremely reliable, being able to detect
100% of culture-confirmed bacterial infections in the study
specimens. Furthermore, it also detected four culture-nega-
tive clinically important gastroenteritis cases, indicating
the high level of efficiency of the assay system. Thus, PCR
may be judged as superior for its rapidity and sensitivity in
the detection of shigellae. Moreover, since this method is
applied without cultivation of the organism on synthetic
media, non-culturable populations of shigellae and Campy-
lobacter spp can also be detected by this method.
In spite of the relatively small size of the study sample,
we believe that our data provide useful information about
the antimicrobial resistance of Shigella and Salmonella
isolates. In order to help practitioners to choose an ade-
quate antimicrobial drug to start empirical therapy in a
506 F.H. Abu Elamreen et al.patient with severe diarrhea without knowledge of a spe-
cific pathogen, we assessed the antimicrobial resistance
patterns of Shigella and Salmonella spp that could be iso-
lated. In most pediatric hospitals the empirical antimicro-
bial drugs used in the treatment of gastroenteritis and
diarrhea patients is intravenous ampicillin, and the physi-
cians usually prescribe trimethoprim/sulfamethoxazole
after discharge from the hospital.
The antibiograms of Shigella isolates showed that 83% of
the isolates were resistant to ampicillin, trimethoprim/
sulfamethoxazole and doxycycline. Piperacillin, cephalexin
and chloramphenicol, cefuroxime, ceftazidime, ceftriax-
one, cefaclor and gentamicin had the low resistance pat-
tern, whereas all the isolates were sensitive to meropenem,
nalidixic acid, ciprofloxacin and amikacin. Antimicrobial
susceptibility testing of Salmonella strains showed that
100% of the isolates were resistant to doxycycline and
nalidixic acid, 67% to ampicillin and trimethoprim/sulfa-
methoxazole. Piperacillin, cefaclor, gentamicin, cefurox-
ime, cephalexin, ciprofloxacin and chloramphenicol had
the low resistance pattern, whereas all the isolates
were sensitive to meropenem, ceftriaxone, ceftazidime
and amikacin.
Several studies have indicated the high resistance of
Salmonella and Shigella to ampicillin, trimethoprim/sulfa-
methoxazole and doxycycline, which is in agreement with our
study.30—32
Shigella is becoming more resistant to the commonly used
antibiotics especially in developing countries.25 However, the
prevalence of resistance to the same antibiotics is lower in
developed countries.33,34 This could be due to the more
appropriate usage of antibiotics in the developed as com-
pared to the developing countries.
The high resistance of our isolates to trimethoprim/sul-
famethoxazole and ampicillin observed may be because
trimethoprim/sulfamethoxazole is the most commonly used
antimicrobial drug for the treatment of gastroenteritis and
diarrhea in primary health care in the Gaza Strip, while
amoxicillin is the most frequently prescribed antibiotic for
the treatment of upper respiratory tract infections (URTIs).
As in developing countries, ampicillin, chloramphenicol and
trimethoprim/sulfamethoxazole are widely used to treat
diarrhea because of their low cost and ready availability.
Most children in our community are treated with antibiotics
that are purchased from private drug outlets.
Misuse of antibiotics has resulted in increased resistance
to most of the commonly used drugs for treatment. A call to
regulate the use of antimicrobials may be necessary. Accord-
ing to our study, ampicillin, trimethoprim/sulfamethoxazole,
and doxycycline should not be used as empirical treatment of
diarrhea in children.
The current study highlights the necessity for continuous
monitoring of antibiotic resistance in diarrhea related bac-
terial pathogens. It is recommended that hospital and private
laboratories in the Gaza Strip test all diarrheal stool samples
for E. coli O157:H7 and Campylobacter, which are not rou-
tinely diagnosed.
We also recommend the introduction of PCR techniques in
order to augment the conventional culture techniques and
thus to improve the quality of detection of the bacterial
enteropathogens. This will make clinical diagnosis better and
help the pediatricians to treat children with diarrhea.Acknowledgement
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